Unveiling the Impact of Synthetic Pseudocannabinoid H4CBD on Metabolic Syndrome in OLETF Rats

The primary aim of the study was to evaluate the efficacy of H4CBD on glucose intolerance and insulin resistance in OLETF rats, an established animal model for human metabolic syndrome —highlighting the utility of the MSG3200 human serum product along the way.